Literature DB >> 16439372

Who benefits from Helicobacter pylori eradication?

Brendan C Delaney.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16439372      PMCID： PMC1352037          DOI： 10.1136/bmj.332.7535.187

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  12 in total

1.  Impact of Helicobacter pylori eradication on dyspepsia, health resource use, and quality of life in the Bristol helicobacter project: randomised controlled trial.

Authors:  J Athene Lane; Liam J Murray; Sian Noble; Matthias Egger; Ian M Harvey; Jenny L Donovan; Prakash Nair; Richard F Harvey
Journal:  BMJ       Date:  2006-01-20

Review 2.  The efficacy of proton pump inhibitors in nonulcer dyspepsia: a systematic review and economic analysis.

Authors:  Paul Moayyedi; Brendan C Delaney; Nimish Vakil; David Forman; Nicholas J Talley
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

Review 3.  Review article: dyspepsia: how to manage and how to treat?

Authors:  N J Talley
Journal:  Aliment Pharmacol Ther       Date:  2002-07       Impact factor: 8.171

4.  Managing dyspepsia without alarm signs in primary care: new national guidance for England and Wales.

Authors:  J M Mason; B Delaney; P Moayyedi; M Thomas; R Walt
Journal:  Aliment Pharmacol Ther       Date:  2005-05-01       Impact factor: 8.171

5.  Helicobacter pylori "test and treat" or endoscopy for managing dyspepsia: an individual patient data meta-analysis.

Authors:  Alexander C Ford; Michelle Qume; Paul Moayyedi; Nicolaas L A Arents; Annmarie T Lassen; Richard F A Logan; Kenneth E L McColl; Paul Myres; Brendan C Delaney
Journal:  Gastroenterology       Date:  2005-06       Impact factor: 22.682

6.  The cost-effectiveness of population Helicobacter pylori screening and treatment: a Markov model using economic data from a randomized controlled trial.

Authors:  J Mason; A T R Axon; D Forman; S Duffett; M Drummond; W Crocombe; R Feltbower; S Mason; J Brown; P Moayyedi
Journal:  Aliment Pharmacol Ther       Date:  2002-03       Impact factor: 8.171

7.  Treating Helicobacter pylori infection in primary care patients with uninvestigated dyspepsia: the Canadian adult dyspepsia empiric treatment-Helicobacter pylori positive (CADET-Hp) randomised controlled trial.

Authors:  Naoki Chiba; Sander J O Veldhuyzen Van Zanten; Paul Sinclair; Ralph A Ferguson; Sergio Escobedo; Eileen Grace
Journal:  BMJ       Date:  2002-04-27

Review 8.  An update of the Cochrane systematic review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews.

Authors:  Paul Moayyedi; Jon Deeks; Nicholas J Talley; Brendan Delaney; David Forman
Journal:  Am J Gastroenterol       Date:  2003-12       Impact factor: 10.864

Review 9.  Eradication therapy for peptic ulcer disease in Helicobacter pylori positive patients.

Authors:  A Ford; B Delaney; D Forman; P Moayyedi
Journal:  Cochrane Database Syst Rev       Date:  2003

10.  Economic evaluation of Helicobacter pylori eradication in the CADET-Hp randomized controlled trial of H. pylori-positive primary care patients with uninvestigated dyspepsia.

Authors:  N Chiba; S J O Veldhuyzen Van Zanten; S Escobedo; E Grace; J Lee; P Sinclair; A Barkun; D Armstrong; A B R Thomson
Journal:  Aliment Pharmacol Ther       Date:  2004-02-01       Impact factor: 8.171
View more
  1 in total

1.  In Vitro Inhibition of Helicobacter pylori Growth by Redox Cycling Phenylaminojuglones.

Authors:  Julio Benites; Héctor Toledo; Felipe Salas; Angélica Guerrero; David Rios; Jaime A Valderrama; Pedro Buc Calderon
Journal:  Oxid Med Cell Longev       Date:  2018-04-24       Impact factor: 6.543
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.